Genomenon

Genomenon
Helps clinicians and researchers interpret millions of genetic variants.
About
Pricing
View pricing page ↗
What does Genomenon do?
Genomenon provides genomic evidence solutions for biopharma and clinical labs, structuring biomedical literature into real-world evidence for precision medicine programs. Their software platforms, including Mastermind and the Cancer Knowledgebase, offer access to curated genetic information for germline and somatic variant interpretation, connecting variants to therapies and clinical trials. They also offer services like Genetic Disease Sponsorship and tailored solutions to support clinical diag…
What is Genomenon's revenue?
StartupHub estimates Genomenon's annual revenue at $18.7M (range $12.0M to $42.2M, 64% confidence), based on comparable companies in the sector.
Where is Genomenon headquartered?
Genomenon is headquartered in Ann Arbor, USA.
When was Genomenon founded?
Genomenon was founded in 2017.
What industry does Genomenon operate in?
Genomenon operates in Genomics, Biotech, HealthTech, MedTech, Clinical Diagnostics, Genetic Testing.
How many employees does Genomenon have?
Genomenon has approximately 137 people on record.
“We are Genomenon! We assist Clinicians and Pathologists in identifying and treating genetic diseases for patients seeking personalized medical care based on their genomic data. Mastermind, by Genomenon, is the first-in-kind genomic search e…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
